Wide Ranks

GMED

Globus Medical, Inc.

85.29

Top Statistics
Market Cap 11 B Forward PE 24.91 Revenue Growth 63.10 %
Current Ratio 2.51 Trailing PE 137.56 Earnings Growth 4223.10 %
Profit Margins 3.69 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA 17.57 Enterprise / Revenue 4.62 Price To Sales Trailing12 Months 4.69
Profitability
Profit Margins 3.69 % Operating Margins 17.67 %
Balance Sheet
Total Cash 694 M Total Cash Per Share 5.10 Total Debt 536 M
Total Debt To Equity 13.18 Current Ratio 2.51 Book Value Per Share 29.94
All Measures
Short Ratio 259.00 % Message Board Id finmb_8793244 Shares Short Prior Month 2 M
Return On Equity 0.0222 City Audubon Uuid 850951f5-8947-3101-97a5-3a83e2560ebf
Previous Close 84.53 First Trade Date Epoch Utc 1 B Book Value 29.94
Beta 1.17 Total Debt 536 M Volume 711825
Price To Book 2.85 Fifty Two Week Low 44.02 Total Cash Per Share 5.10
Total Revenue 2 B Shares Short Previous Month Date 1 B Target Median Price 88.00
Audit Risk 7 Max Age 86400 Recommendation Mean 2.13
Sand P52 Week Change 0.3133 Operating Margins 17.67 % Target Mean Price 90.54
Net Income To Common 91 M Ask 85.40 Short Percent Of Float 0.0274
Implied Shares Outstanding 136 M Last Fiscal Year End 1 B Trailing Peg Ratio 229.06 %
Average Daily Volume10 Day 953930 Average Volume10days 953930 Total Cash 694 M
Next Fiscal Year End 1 B Revenue Per Share 18.22 Held Percent Insiders 0.0062
Ebitda Margins 26.30 % Trailing PE 137.56 Date Short Interest 1 B
Most Recent Quarter 1 B Share Holder Rights Risk 10 Regular Market Previous Close 84.53
Target Low Price 80.00 Gmt Off Set Milliseconds -18000000 Fifty Day Average 75.67
Open 84.85 Free Cashflow 473 M State PA
Dividend Yield 0.00 % Return On Assets 0.0473 Time Zone Short Name EST
Board Risk 9 Trailing Eps 0.6200 Day Low 84.44
Address1 2560 General Armistead Avenue Shares Outstanding 113 M Compensation Risk 6
Price Hint 2 Target High Price 100.00 Website https://www.globusmedical.com
52 Week Change 0.8987 Average Volume 813917 Earnings Quarterly Growth 5094.00 %
Forward Eps 3.42 Recommendation Key buy Compensation As Of Epoch Date 1 B
Quick Ratio 157.40 % Is_sp_500 False Regular Market Day High 85.73
Profit Margins 3.69 % Debt To Equity 13.18 Fifty Two Week High 85.74
Day High 85.73 Shares Short 2 M Regular Market Open 84.85
Industry Key medical-devices Bid 85.67 Earnings Growth 4223.10 %
Enterprise To Revenue 4.62 Revenue Growth 63.10 % Shares Percent Shares Out 0.0205
Operating Cashflow 414 M Currency USD Time Zone Full Name America/New_York
Market Cap 11 B Is_nasdaq_100 False Zip 19403
Quote Type EQUITY Industry Medical Devices Long Name Globus Medical, Inc.
Overall Risk 9 Regular Market Day Low 84.44 Held Percent Institutions 0.8208
Current Price 85.29 Enterprise To Ebitda 17.57 Financial Currency USD
Current Ratio 2.51 Gross Margins 67.05 % Industry Disp Medical Devices
Number Of Analyst Opinions 13 Country United States Float Shares 112 M
Two Hundred Day Average 65.83 Governance Epoch Date 1 B Enterprise Value 11 B
Price To Sales Trailing12 Months 4.69 Forward PE 24.91 Regular Market Volume 711825
Ebitda 652 M Exchange NYQ
Go to Yahoo Finance Go to Seeking Alpha 
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.

The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives.

It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants.

In addition, the company distributes human cell, tissue, and cellular and tissue-based products.

It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents.

Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.